Related references
Note: Only part of the references are listed.Purification of autophagosomes from rat hepatocytes
Per O. Seglen et al.
AUTOPHAGY (2010)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
The Bcl-xL Inhibitor, ABT-737, Efficiently Induces Apoptosis and Suppresses Growth of Hepatoma Cells in Combination with Sorafenib
Hayato Hikita et al.
HEPATOLOGY (2010)
Drug Therapy: Sorafenib
Richard S. Finn
HEPATOLOGY (2010)
Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro
Anders Ullen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony
Kathryn G. Foster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide
Dennis J. Goussetis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
Satoshi Shimizu et al.
JOURNAL OF HEPATOLOGY (2010)
Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
Margaret A. Park et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells
Damia Tormo et al.
CANCER CELL (2009)
Autophagy Is Activated by TGF-β and Potentiates TGF-β-Mediated Growth Inhibition in Human Hepatocellular Carcinoma Cells
Kunihiko Kiyono et al.
CANCER RESEARCH (2009)
The Double-Edged Sword of Autophagy Modulation in Cancer
Eileen White et al.
CLINICAL CANCER RESEARCH (2009)
Sorafenib Inhibits Signal Transducer and Activator of Transcription-3 Signaling in Cholangiocarcinoma Cells by Activating the Phosphatase Shatterproof 2
Boris R. A. Blechacz et al.
HEPATOLOGY (2009)
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
Carson C. Thoreen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
The role of TOR in autophagy regulation from yeast to plants and mammals
Sandra Diaz-Troya et al.
AUTOPHAGY (2008)
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation
Margaret A. Park et al.
CANCER BIOLOGY & THERAPY (2008)
Association of Autophagy Defect with a Malignant Phenotype and Poor Prognosis of Hepatocellular Carcinoma
Zhen-Bin Ding et al.
CANCER RESEARCH (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3
Shunsuke Kimura et al.
AUTOPHAGY (2007)
TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer
S. P. Hussain et al.
ONCOGENE (2007)
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Ravi K. Amaravadi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
DRAM, a p53-induced modulator of autophagy, is critical for apoptosis
Diane Crighton et al.
CELL (2006)
p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death
G Bjorkoy et al.
JOURNAL OF CELL BIOLOGY (2005)
Another way to die: autophagic programmed cell death
Y Tsujimoto et al.
CELL DEATH AND DIFFERENTIATION (2005)
Raf kinase as a target for anticancer therapeutics
SS Sridhar et al.
MOLECULAR CANCER THERAPEUTICS (2005)
The dynamics of autophagy visualized in live cells - From autophagosome formation to fusion with endo/lysosomes
Edward T. W. Bampton et al.
AUTOPHAGY (2005)
The role of autophagy in cancer development and response to therapy
Y Kondo et al.
NATURE REVIEWS CANCER (2005)
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
T Kanzawa et al.
CELL DEATH AND DIFFERENTIATION (2004)
Autophagy: a regulated bulk degradation process inside cells
T Yoshimori
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Share Paper
